Respiratory Syncytial Virus (RSV) Diagnostics Market
Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis By Technology (RSV Molecular Diagnostics, Immunoassays, Differential Light Scattering, Artificial Intelligence, Liposomes, Flow Cytometry, Chromatography, Diagnostic Imaging), By End Users - Global Insights to 2031
Analysis of Respiratory Syncytial Virus (RSV) Diagnostics market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Market Outlook for Respiratory Syncytial Virus (RSV) Diagnostics
A newly published industry analysis by Fact.MR estimates revenue from the global respiratory syncytial virus (RSV) diagnostics market to reach US$ 1.3 Bn by 2031, surging at a CAGR of 9%. Demand for RSV diagnostic kits & assays to remain high and reach a valuation of US$ 720 Mn by the end of 2031.
Amongst the many factors credited to accelerating demand for respiratory syncytial virus diagnostics is rising burden of RSV infections, growing demand for molecular diagnostic tests, and increasing approvals of RSV diagnostic kits & assays.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Key Points Covered in Respiratory Syncytial Virus Diagnostics Industry Survey:
- Market Estimates and Forecasts (2016 to 2031)
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise and Region-wise Analysis
- Competition Mapping and Benchmarking
- Market Share Analysis
- COVID-19 Impact on Demand for Respiratory Syncytial Virus Diagnostics and How to Navigate
- Recommendation on Key Winning Strategies
Respiratory Syncytial Virus Diagnostics Marketplace Analysis from 2016 to 2020 Vs Demand Outlook for 2021 to 2031
The market for respiratory syncytial virus diagnostics grew from US$ 575 Mn in 2017 to US$ 678 Mn in 2020, and is anticipated to top US$ 1.3 Bn by 2031.
Respiratory syncytial virus is a very common and contagious virus that infects the respiratory track of most children before 1-2 years of age. RSV is the most common cause of bronchiolitis and pneumonia. It also causes respiratory illness in adults, and it can occasionally cause serious infection that needs hospitalization due to breathing complications with bronchiolitis or pneumonia.
For diagnosis, doctors mostly rely on a blood or urine test to look for bacterial infection, chest X-ray for checking any signs of pneumonia, and a test of material scraped out from the patient’s nose or mouth.
Globally, cases of RSV infections are on the rise, which is fuelling demand for rapid diagnostic techniques. According to the Centre of Disease Control and Prevention (CDC), each year, on an average, RSV leads to the hospitalizations of around 1,32,000 - 1,72,000 children below the age of five, and the death of around 14,000 adults above the age of 65, in the United States alone.
As the clinical symptoms of RSV infections are indistinguishable from other respiratory infections, there is growing need for rapid, specific, and sensitive diagnostic techniques.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
How are Technological Advancements Aiding Demand Growth of RSV Diagnostics?
New technologies such as filament-based antibody detection assays, thin layer-based amperometric enzyme immunoassay (EIA), and multiplex virus testing are in the final stage of development.
Furthermore, nucleic acid amplification techniques and loop-mediated isothermal amplification will soon be aligned with point of care (POC) devices. This will allow testing to be performed using a one-step kit, which will require only the addition of a patient sample.
Also, the nanoparticle technology, which has the potential to bring about a four-fold improvement in viral detection as compared to RT-PCR, is under development.
Similarly, plasmonic detection techniques such as localized surface plasmon resonance (LSPR) spectroscopy (which uses metallic nanomaterials by exploiting physicochemical peculiarities) are under development with POC detection devices.
This is considered as a major development as methods such as LSPR spectroscopy offer rapid diagnostics and superior sensitivity & affordability as compared to techniques such as surface-enhanced Raman spectroscopy (SERS) and Polymerase Chain Reaction (PCR) coupled with electrospray ionization mass spectrometry (PCR-ESI-MS), which are not cost-effective, cumbersome to perform, and are more limited to research purposes.
Over the next few years, all the above-mentioned technologies are expected to be included in commercialized diagnostic methods. This is considered as a potential growth area for players involved in RSV diagnostics.
Why is Demand for Molecular Testing of RSV Infections on the Rise?
Demand for molecular testing of RSV infections is increasing in hospitals and reference laboratories. Moreover, a number of Clinical Laboratory Improvement Amendment (CLIA) waivers and U.S. FDA clearances are supporting the adoption of molecular diagnostic tests in physician offices and urgent care clinics.
Since RSV infections have a higher prevalence among infants and young children, adoption of molecular diagnostics is increasing as compared to immunoassays in this patient group.
Rapid immunoassays are preferred whenever a quick estimation of the infection is required in inpatient and outpatient settings as well as for community surveillance. However, for the confirmation of the infection, molecular diagnostic tests are deployed to better evaluate the entire course of infection.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
What is the Regional Demand Outlook for RSV Diagnostics?
The global market for RSV diagnostics is dominated by North America, followed by Europe. North America will continue to dominate the landscape over the forecast period.
However, the respiratory syncytial virus diagnostics market in Asia Pacific is expected to witness higher gro wth across the assessment period. Increasing burden of infectious diseases such as RSV and focus of major players on emerging Asia Pacific countries are driving market growth in the region.
Country-wise Analysis
Why is China Emerging as an Epicentre for Market Players Involved in Respiratory Syncytial Virus Diagnostics?
In China, the RSV diagnostics market is expected to reach a valuation of US$ 253 Mn by 2031.
China, being the epicentre of the novel coronavirus disease, is expected to garner massive growth for RSV diagnostics. Besides, infant population is also on the rise in the country.
Strong steps by governments such as creating awareness about the respiratory syncytial virus through various initiatives are also expected to prove as a growth multiplier for the market in China.
Category-wise Analysis
Why Do Kits & Assays Account for the Largest Share in the Market for RSV Diagnostics?
Kits & assays account for more than 36% share of the global market for RSV diagnostics. Factors driving the growth of this segment include increasing infections of RSV in new-borns, infants, and young children, and growing demand for kits & assays for RSV diagnosis.
Due to ease of usage and quick accurate results, demand for RSV diagnostic kits & assays has been on the rise across the world.
What Has Been the Impact of COVID-19 on RSV Diagnostics?
The spread of COVID-19 has risen demand for rapid testing kits worldwide. As the novel coronavirus impacts the respiratory system, several companies are offering respiratory syncytial diagnostic test kits for testing COVID-19.
For instance, the U.S. FDA recently approved the use of Mesa Biotech’s Accula device for COVID-19, which gives results in around 30 minutes.
Use of such RSV diagnostic products for COVID-19 testing is expected to fuel the growth of the market substantially.
Competitive Landscape
The respiratory syncytial virus diagnostics landscape is highly fragmented in nature. Manufacturers are focusing on technological innovations for speeding up the diagnosis of the respiratory syncytial virus.
Frequent mergers and acquisitions also take place in the market. The acquisition of Sigma Aldrich by Merck KGaA is a classic example.
Respiratory Syncytial Virus Diagnostics Market Report Scope
| Attribute | Detail |
|---|---|
| Forecast Period | 2021 to 2031 |
| Historical Data Available for | 2016 to 2020 |
| Market Analysis | US$ Mn for Value & ‘000 Units for Volume |
| Key Regions Covered | North America; Europe; Asia Pacific; Central & South America; Middle East & Africa |
| Key Market Segments Covered | USA, Canada, Germany, France, the UK, Russia, Italy, China, Japan, South Korea, India, Australia, Middle East, Latin America |
| Key Market Segments Covered | Technology, End User, Region |
| Key Companies Profiled | Abbott Laboratories; Becton; Dickinson and Company; BioMérieux SA; Bio-Rad Laboratories; Coris BioConcept; DiaSorin Molecular LLC (DiaSorin Inc); F. Hoffmann-La Roche AG; Merck KgaA; Quest Diagnostics Incorporated; Quidel Corporation; Thermo Fisher Scientific |
| Pricing | Available upon Request |
Key Market Segments Covered in Respiratory Syncytial Virus Diagnostics Industry Research
-
By Technology
- RSV Molecular Diagnostics
- RSV Monoclonal Antibodies
- Immunoassays
- Differential Light Scattering
- Artificial Intelligence
- Liposomes
- Flow Cytometry
- Chromatography
- Diagnostic Imaging
- Gel Microdroplets
-
By End Users
- Respiratory Syncytial Virus Diagnostics at Hospitals
- Respiratory Syncytial Virus Diagnostics at Nursing Homes
- Respiratory Syncytial Virus Diagnostics at Commercial Laboratories
- Respiratory Syncytial Virus Diagnostics at Public Health Laboratories
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Key Market Trends
- 4. Key Success Factors
- 5. Market Background
- 6. Global Market Volume (Units) Analysis 2016 to 2020 and Forecast, 2021 to 2031
- 7. Global Market - Pricing Analysis
- 8. Global Market Value Analysis 2016 to 2020 and Forecast, 2021 to 2031
- 9. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Technology
- 9.1. Molecular Diagnostics
- 9.2. Monoclonal Antibodies
- 9.3. Immunoassays
- 9.4. Differential Light Scattering
- 9.5. Artificial Intelligence
- 9.6. Liposomes
- 9.7. Flow Cytometry
- 9.8. Chromatography
- 9.9. Diagnostic Imaging
- 9.10. Gel Microdroplets
- 10. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by End User
- 10.1. Hospitals
- 10.2. Nursing Homes
- 10.3. Commercial Laboratories
- 10.4. Public Health Laboratories
- 11. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Region
- 11.1. North America
- 11.2. Latin America
- 11.3. Europe
- 11.4. East Asia
- 11.5. South Asia
- 11.6. Oceania
- 11.7. Middle East and Africa (MEA)
- 12. North America Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 13. Latin America Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 14. Europe Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 15. South Asia Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 16. East Asia Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 17. Oceania Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 18. Middle East and Africa Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 19. Key and Emerging Countries Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 20. Market Structure Analysis
- 21. Competition Analysis
- 21.1. BioMérieux
- 21.2. Abbott
- 21.3. Roche, BD
- 21.4. Thermo Fisher
- 21.5. Luminex
- 21.6. Danaher
- 21.7. Biocartis
- 21.8. Hologic
- 22. Assumptions and Acronyms Used
- 23. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (‘000 Units) Analysis and Opportunity Assessment 2016 to 2031, By Technology
Table 02: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Technology
Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By End User
Table 04: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Region
Table 05: North America Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 06: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Technology
Table 07: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By End User
Table 08: Latin America Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 09: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Technology
Table 10: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By End User
Table 11: Europe Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 12: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Technology
Table 13: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By End User
Table 14: South Asia Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 15: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Technology
Table 16: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By End User
Table 17: East Asia Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 18: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Technology
Table 19: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By End User
Table 20: Oceania Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 21: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Technology
Table 22: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By End User
Table 23: Middle East and Africa Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 24: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Technology
Table 25: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Volume (in 000' Units) Analysis, 2016 to 2020
Figure 02: Global Market Volume Forecast (in 000' Units), 2021 to 2031
Figure 03: Pricing Analysis (US$) Per Product, By Region, 2020
Figure 04: Pricing Analysis (US$) Per Product, By Region, 2020
Figure 05: Global Market Value Analysis (US$ Mn), 2016 to 2020
Figure 06: Global Market Value Forecast (US$ Mn), 2021 to 2031
Figure 07: Global Market Absolute $ Opportunity, 2021 to 2031
Figure 08: Global Market Share Analysis (%), By Technology, 2021 to 2031
Figure 09: Global Market Y-o-Y Analysis (%), By Technology, 2021 to 2031
Figure 10: Global Market Attractiveness Analysis by Technology, 2021 to 2031
Figure 11: Global Market Share Analysis (%), By End User, 2021 to 2031
Figure 12: Global Market Y-o-Y Analysis (%), By End User, 2021 to 2031
Figure 13: Global Market Attractiveness Analysis by End User, 2021 to 2031
Figure 14: Global Market Share Analysis (%), By Region, 2021 to 2031
Figure 15: Global Market Y-o-Y Analysis (%), By Region, 2021 to 2031
Figure 16: Global Market Attractiveness Analysis by Region, 2021 to 2031
Figure 17: North America Market Value Share, By Technology, 2021 (E)
Figure 18: North America Market Value Share, By End User, 2021 (E)
Figure 19: North America Market Value Share, By Country, 2021 (E)
Figure 20: North America Market Value Analysis (US$ Mn), 2016 to 2020
Figure 21: North America Market Value Forecast (US$ Mn), 2021 to 2031
Figure 22: North America Market Attractiveness Analysis by Technology, 2021 to 2031
Figure 23: North America Market Attractiveness Analysis by End User, 2021 to 2031
Figure 24: North America Market Attractiveness Analysis by Country, 2021 to 2031
Figure 25: Latin America Market Value Share, By Technology, 2021 (E)
Figure 26: Latin America Market Value Share, By End User, 2021 (E)
Figure 27: Latin America Market Value Share, By Country, 2021 (E)
Figure 28: Latin America Market Value Analysis (US$ Mn), 2016 to 2020
Figure 29: Latin America Market Value Forecast (US$ Mn), 2021 to 2031
Figure 30: Latin America Market Attractiveness Analysis by Technology, 2021 to 2031
Figure 31: Latin America Market Attractiveness Analysis by End User, 2021 to 2031
Figure 32: Latin America Market Attractiveness Analysis by Country, 2021 to 2031
Figure 33: Europe Market Value Share, By Technology, 2021 (E)
Figure 34: Europe Market Value Share, By End User, 2021 (E)
Figure 35: Europe Market Value Share, By Country, 2021 (E)
Figure 36: Europe Market Value Analysis (US$ Mn), 2016 to 2020
Figure 37: Europe Market Value Forecast (US$ Mn), 2021 to 2031
Figure 38: Europe Market Attractiveness Analysis by Technology, 2021 to 2031
Figure 39: Europe Market Attractiveness Analysis by End User, 2021 to 2031
Figure 40: Europe Market Attractiveness Analysis by Country, 2021 to 2031
Figure 41: South Asia Market Value Share, By Technology, 2021 (E)
Figure 42: South Asia Market Value Share, By End User, 2021 (E)
Figure 43: South Asia Market Value Share, By Country, 2021 (E)
Figure 44: South Asia Market Value Analysis (US$ Mn), 2016 to 2020
Figure 45: South Asia Market Value Forecast (US$ Mn), 2021 to 2031
Figure 46: South Asia Market Attractiveness Analysis by Technology, 2021 to 2031
Figure 47: South Asia Market Attractiveness Analysis by End User, 2021 to 2031
Figure 48: South Asia Market Attractiveness Analysis by Country, 2021 to 2031
Figure 49: East Asia Market Value Share, By Technology, 2021 (E)
Figure 50: East Asia Market Value Share, By End User, 2021 (E)
Figure 51: East Asia Market Value Share, By Country, 2021 (E)
Figure 52: East Asia Market Value Analysis (US$ Mn), 2016 to 2020
Figure 53: East Asia Market Value Forecast (US$ Mn), 2021 to 2031
Figure 54: East Asia Market Attractiveness Analysis by Technology, 2021 to 2031
Figure 55: East Asia Market Attractiveness Analysis by End User, 2021 to 2031
Figure 56: East Asia Market Attractiveness Analysis by Country, 2021 to 2031
Figure 57: Oceania Market Value Share, By Technology, 2021 (E)
Figure 58: Oceania Market Value Share, By End User, 2021 (E)
Figure 59: Oceania Market Value Share, By Country, 2021 (E)
Figure 60: Oceania Market Value Analysis (US$ Mn), 2016 to 2020
Figure 61: Oceania Market Value Forecast (US$ Mn), 2021 to 2031
Figure 62: Oceania Market Attractiveness Analysis by Technology, 2021 to 2031
Figure 63: Oceania Market Attractiveness Analysis by End User, 2021 to 2031
Figure 64: Oceania Market Attractiveness Analysis by Country, 2021 to 2031
Figure 65: Middle East and Africa Market Value Share, By Technology, 2021 (E)
Figure 66: Middle East and Africa Market Value Share, By End User, 2021 (E)
Figure 67: Middle East and Africa Market Value Share, By Country, 2021 (E)
Figure 68: Middle East and Africa Market Value Analysis (US$ Mn), 2016 to 2020
Figure 69: Middle East and Africa Market Value Forecast (US$ Mn), 2021 to 2031
Figure 70: Middle East and Africa Market Attractiveness Analysis by Technology, 2021 to 2031
Figure 71: Middle East and Africa Market Attractiveness Analysis by End User, 2021 to 2031
Figure 72: Middle East and Africa Market Attractiveness Analysis by Country, 2021 to 2031
Figure 73: U. S. Market Value Analysis (US$ Mn), 2021 & 2031
Figure 74: U. S. Market Value Share, By Technology, 2021 (E)
Figure 75: U. S. Market Value Share, By End User, 2021 (E)
Figure 76: Canada Market Value Analysis (US$ Mn), 2021 & 2031
Figure 77: Canada Market Value Share, By Technology, 2021 (E)
Figure 78: Canada Market Value Share, By End User, 2021 (E)
Figure 79: Mexico Market Value Analysis (US$ Mn), 2021 & 2031
Figure 80: Mexico Market Value Share, By Technology, 2021 (E)
Figure 81: Mexico Market Value Share, By End User, 2021 (E)
Figure 82: Brazil Market Value Analysis (US$ Mn), 2021 & 2031
Figure 83: Brazil Market Value Share, By Technology, 2021 (E)
Figure 84: Brazil Market Value Share, By End User, 2021 (E)
Figure 85: U. K. Market Value Analysis (US$ Mn), 2021 & 2031
Figure 86: U. K. Market Value Share, By Technology, 2021 (E)
Figure 87: U. K. Market Value Share, By End User, 2021 (E)
Figure 88: Germany Market Value Analysis (US$ Mn), 2021 & 2031
Figure 89: Germany Market Value Share, By Technology, 2021 (E)
Figure 90: Germany Market Value Share, By End User, 2021 (E)
Figure 91: France Market Value Analysis (US$ Mn), 2021 & 2031
Figure 92: France Market Value Share, By Technology, 2021 (E)
Figure 93: France Market Value Share, By End User, 2021 (E)
Figure 94: Italy Market Value Analysis (US$ Mn), 2021 & 2031
Figure 95: Italy Market Value Share, By Technology, 2021 (E)
Figure 96: Italy Market Value Share, By End User, 2021 (E)
Figure 97: Spain Market Value Analysis (US$ Mn), 2021 & 2031
Figure 98: Spain Market Value Share, By Technology, 2021 (E)
Figure 99: Spain Market Value Share, By End User, 2021 (E)
Figure 100: Russia Market Value Analysis (US$ Mn), 2021 & 2031
Figure 101: Russia Market Value Share, By Technology, 2021 (E)
Figure 102: Russia Market Value Share, By End User, 2021 (E)
Figure 103: China Market Value Analysis (US$ Mn), 2021 & 2031
Figure 104: China Market Value Share, By Technology, 2021 (E)
Figure 105: China Market Value Share, By End User, 2021 (E)
Figure 106: Japan Market Value Analysis (US$ Mn), 2021 & 2031
Figure 107: Japan Market Value Share, By Technology, 2021 (E)
Figure 108: Japan Market Value Share, By End User, 2021 (E)
Figure 109: South Korea Market Value Analysis (US$ Mn), 2021 & 2031
Figure 110: South Korea Market Value Share, By Technology, 2021 (E)
Figure 111: South Korea Market Value Share, By End User, 2021 (E)
Figure 112: India Market Value Analysis (US$ Mn), 2021 & 2031
Figure 113: India Market Value Share, By Technology, 2021 (E)
Figure 114: India Market Value Share, By End User, 2021 (E)
Figure 115: ASEAN Market Value Analysis (US$ Mn), 2021 & 2031
Figure 116: ASEAN Market Value Share, By Technology, 2021 (E)
Figure 117: ASEAN Market Value Share, By End User, 2021 (E)
Figure 118: Australia Market Value Analysis (US$ Mn), 2021 & 2031
Figure 119: Australia Market Value Share, By Technology, 2021 (E)
Figure 120: Australia Market Value Share, By End User, 2021 (E)
Figure 121: New Zealand Market Value Analysis (US$ Mn), 2021 & 2031
Figure 122: New Zealand Market Value Share, By Technology, 2021 (E)
Figure 123: New Zealand Market Value Share, By End User, 2021 (E)
Figure 124: GCC Countries Market Value Analysis (US$ Mn), 2021 & 2031
Figure 125: GCC Countries Market Value Share, By Technology, 2021 (E)
Figure 126: GCC Countries Market Value Share, By End User, 2021 (E)
Figure 127: Turkey Market Value Analysis (US$ Mn), 2021 & 2031
Figure 128: Turkey Market Value Share, By Technology, 2021 (E)
Figure 129: Turkey Market Value Share, By End User, 2021 (E)
Figure 130: South Africa Market Value Analysis (US$ Mn), 2021 & 2031
Figure 131: South Africa Market Value Share, By Technology, 2021 (E)
Figure 132: South Africa Market Value Share, By End User, 2021 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the projected market size for respiratory syncytial virus diagnostics?
The global respiratory syncytial virus (RSV) diagnostics market is slated to reach US$ 1.3 Bn by 2031-end.
What is the anticipated CAGR for the RSV diagnostics market through 2031?
The market for RSV diagnostics is anticipated to surge at a CAGR of 9% from 2021 to 2031.
How is demand for RSV diagnostics shaping up in China?
Revenue from RSV diagnostics in China is expected to top US$ 253 Mn by 2031.
What are the key driving factors for the demand growth of RSV diagnostics?
Rising prevalence of chronic diseases, including respiratory disorders, in the neonatal population and growing awareness among parents are driving market growth.
Who are the top market players providing RSV diagnostic products?
Luminex, Hologic, Danaher, Thermo Fisher Scientific, Biomérieux, and Fast Track Diagnostics are the top players operating in this industry.
Which type of RSV diagnostic test dominates the global market?
RSV diagnostic kits & assays are slated to dominate the global market over the next ten years.
Respiratory Syncytial Virus (RSV) Diagnostics Market